LONG-TREM FOLLOW-UP RESULTS IN PATIENTS TREATED WITH CONCURRENT RADIATION AND CHEMOTHERAPY FOR ESOPHAGEAL CARCINOMA
- VernacularTitle:放疗加化疗综合治疗食管癌的远期疗效分析
- Author:
Xiaoli WANG
;
Zhefang ZHANG
;
Wuyi TANG
- Publication Type:Journal Article
- Keywords:
Esophageal carcinoma Radiation therapy Chemotherapy
- From:
Chinese Journal of Radiation Oncology
1992;0(01):-
- CountryChina
- Language:Chinese
-
Abstract:
From Jan. 1985 to Feb. 1986, 180 patients with esophageal, carcinoma were entered into this study. All patients were inoperable or who refused operation. Because parts of the cases data were lost, the number of analysed cases was 137. All patients were followed for at least 5-year. Patients were randomly divided into four groups: A, control group (radiation alone with the dose of 55～65 Gy in 5～7 weeks) 32 patients. B, radiation plus ping yangmycin (10mg im, twice a week), 37 patients. C, radiation plus cisplatin (20mg, iv. twice a week) 40 patients.D, radiation plus both 28 patients. The 3-year survival rates were 15.6%, 21.6%, 42.5% and 39.3%, respectively. There were significantly differences between C and A or D and B groups, respectively (P
